Anti-endothelial properties of 1,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of calcitriol

Journal of Steroid Biochemistry and Molecular Biology

Volumn 89-90, Issue , 2004, Pages 427-431

  Furigay, Paul ^a   Swamy, Narasimha ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

1,25 Dihydroxy 3 epi vitamin D3 (3 epiD3); Apoptosis; Calcitriol; Caspase 3; Endothelial cells; G0 G1 arrest; Proliferation inhibition

Indexed keywords

CALCITRIOL; CALCITRIOL DERIVATIVE; CASPASE 3; DNA FRAGMENT; DRUG METABOLITE; GENOMIC DNA;

APOPTOSIS; CALCIUM BLOOD LEVEL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; STRUCTURE ACTIVITY RELATION;

APOPTOSIS; CASPASE 3; CASPASES; CELL DIVISION; CELLS, CULTURED; CHOLECALCIFEROL; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS;

EID: 3042550032     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.03.011     Document Type: Conference Paper

References (22)

1. R.P. Heaney, Vitamin D: role in the calcium economy, in: D. Feldman, F.H. Glorieux, J.W. Pike (Eds.), Vitamin D. Academic Press, San Diego, 1997, pp. 485-498.
2. J.P.T.M. van Leeuwen, H.A.P. Pols, Vitamin D: anticancer and differentiation, in: D. Feldman, F.H. Glorieux, J.W. Pike (Eds.), Vitamin D. Academic Press, San Diego, 1997, pp. 1089-1105.
3. 3 inhibits angiogenesis in vitro and in vivo. Circ. Res. 87:2000;214-220
4. 3 and vitamin D analogs on tumor-derived endothelial cells. Endocrinology. 143:2002;2508-2514
5. Folkman J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer. Inst. 82:1990;4-6
6. Pike S.E., Yao L., Setsuda J., et al. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood. 94:1999;2461-2468
7. Dimitroff C.J., Klohs W., Sharma A., et al. Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy. Invest. New Drugs. 17:1999;121-135
8. Boehm T., Folkman J., Browder T., O'Reilly M.S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 390:1997;404-407
9. 3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J. Clin. Invest. 83:1989;1903-1915
10. 3 analogues. Eur. J. Pharmacol. 178:1990;247-250
11. Smith D.C., Johnson C.S., Freeman C.C., et al. A phase I trial of calcitriol (1, 25-dihydroxy-cholecalciferol) in patients with advanced malignancy. Clin. Cancer Res. 5:1999;1339-1345
12. Colston K.W., Chander S.K., Mackay A.G., Coombes R.C., et al. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem. Pharmacol. 44:1992;693-702
13. Norman A.W., Bouillon R., Farach-Carson M.C. Demonstration that 1 beta, 25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha, 25-dihydroxyvitamin D. J. Biol. Chem. 268:1993;20022-20030
14. Brown A.J., Ritter C., Slatopolsky E., et al. 1Alpha, 25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha, 25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. J. Cell. Biochem. 73:1999;106-113
15. Gratzner H.G. Monoclonal antibody to 5-bromo- and 5-iodo-deoxyuridine: a new reagent for detection of DNA replication. Science. 218:1982;474-475
16. M.G. Ormerod (Ed.), A Practical Approach in Flow Cytometry, Oxford University Press, New York, 1990, pp. 69-81.
17. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68:1999;383-424
18. Eckhardt S.G., Pluda J.M. Development of angiogenesis inhibitors for cancer therapy. Invest. New Drugs. 15:1997;1-3
19. Bicknell R., Harris A.L. Mechanisms and therapeutic implications of angiogenesis. Curr. Opin. Oncol. 8:1996;60-65
20. Folkman J. Angiogenesis: initiation and modulation. Symp. Fundam. Cancer Res. 36:1983;201-208
21. Nishii Y., Okano T. History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)calcitriol (ED-71). Steroids. 66:2001;137-146
22. Solorzano C.C., Jung Y.D., Bucana C.D., et al. In vivo intracellular signaling as a marker of antiangiogenic activity. Cancer Res. 61:2001;7048-7051